Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular pathways leading to cancer cachexia.

Michael J Tisdale1

  • 1Cancer Biochemistry, School of Life and Health Sciences, Aston University, Birmingham, United Kingdom. m.j.tisdale@aston.ac.uk

Physiology (Bethesda, Md.)
|September 22, 2005
PubMed
Summary

Cancer cachexia causes significant weight loss, increasing patient mortality. Both tumor and host factors contribute to muscle and fat tissue breakdown through enhanced degradative pathways.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simple ammonium salts acting on sigma-1 receptors yield potential treatments for cancer and depression.

Scientific reports·2020
Same author

Ken Fearon.

Cell metabolism·2016
Same author

In vitro assessment of the combined effect of eicosapentaenoic acid, green tea extract and curcumin C3 on protein loss in C2C12 myotubes.

In vitro cellular & developmental biology. Animal·2016
Same author

Comparison of the anticatabolic effects of leucine and Ca-β-hydroxy-β-methylbutyrate in experimental models of cancer cachexia.

Nutrition (Burbank, Los Angeles County, Calif.)·2014
Same author

Attenuation of muscle wasting in murine C2C 12 myotubes by epigallocatechin-3-gallate.

Journal of cachexia, sarcopenia and muscle·2014
Same author

Role of β-adrenergic receptors in the oral activity of zinc-α2-glycoprotein (ZAG).

Endocrinology·2012

Area of Science:

  • Oncology
  • Metabolism
  • Physiology

Background:

  • Cancer cachexia is a complex metabolic syndrome characterized by involuntary weight loss.
  • It significantly impacts cancer patient morbidity and mortality.
  • Both tumor-derived and host-derived factors contribute to the pathophysiology of cachexia.

Purpose of the Study:

  • To elucidate the molecular mechanisms driving tissue catabolism in cancer cachexia.
  • To investigate the roles of tumor and host factors in metabolic dysregulation.

Main Methods:

  • Analysis of gene expression in skeletal muscle and adipose tissue.
  • Investigation of signaling pathways involved in protein and lipid degradation.

Main Results:

  • Identified upregulation of key degradative pathways in skeletal muscle and adipose tissue.
  • Demonstrated the contribution of both tumor and host factors to these catabolic processes.

Conclusions:

  • Cancer cachexia involves coordinated upregulation of catabolic pathways in peripheral tissues.
  • Targeting these pathways may offer therapeutic strategies to mitigate weight loss and improve outcomes in cancer patients.

Related Experiment Videos